High-Intensity Exercise for Older Adults with HIV
(HEALTH Trial)
Trial Summary
What is the purpose of this trial?
This is a multi-site, randomized, single-blind (researchers), active treatment concurrent control trial with individuals aged 50-80 living with HIV who experience fatigue and live a sedentary lifestyle. The overall goals of this proposal are to determine whether high-intensity interval training (HIIT) can overcome physical function impairments and increased fatigue (Aim 1) and impairments in mitochondrial bioenergetics of older people with HIV (PWH) to a greater extent than continuous moderate-intensity exercise (CME) (Aim 2). The investigators further seek to determine whether a biobehavioral coaching intervention following either HIIT or CME can promote long-term adherence to physical activity (Aim 3), a crucial component of the sustainability of the intervention. This study will enroll 100 participants in Aurora, Colorado and Seattle, Washington. Data collection will occur at each visit, with baseline data collected at the initial visit. A 3-month follow-up will be conducted over the phone from the date of the final visit. The initial enrollment goal of 100 was increased to 120 in 2023 to facilitate a larger number of participants with key secondary outcomes.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on sex hormone therapy or other hormone replacement, you must have been on a stable dose for more than 3 months. Also, if you are undergoing a muscle biopsy, you may need to stop taking certain medications like aspirin for 7 days before the procedure.
What data supports the effectiveness of the treatment High-Intensity Exercise for Older Adults with HIV?
Research shows that high-intensity interval training (HIIT) can significantly improve cardiorespiratory fitness in older adults with HIV, with a 17.1% increase in VO2peak, which measures how well the body uses oxygen during exercise. This suggests that HIIT may help counteract the accelerated aging process seen in people with HIV.12345
Is high-intensity exercise safe for older adults with HIV?
How does high-intensity exercise differ from other treatments for older adults with HIV?
High-intensity exercise, specifically high-intensity interval training (HIIT), is unique because it focuses on improving physical function and reducing fatigue in older adults with HIV, which is not typically addressed by standard treatments. This approach also includes biobehavioral coaching and mobile health text messaging to encourage long-term adherence to physical activity, making it a comprehensive lifestyle intervention rather than just a medical treatment.24689
Research Team
Kristine Erlandson, MD, MS
Principal Investigator
University of Colorado, Denver
Allison Webel, PhD, RN
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for adults aged 50-80 with HIV who are sedentary, experience fatigue, and have been on stable antiretroviral therapy with a controlled viral load. They must be willing to commit to a 16-week exercise program and have no major health issues like severe heart disease or uncontrolled diabetes that could interfere with safe participation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either high-intensity interval training (HIIT) or continuous moderate-intensity exercise (CME) to assess physical function and fatigue
Follow-up
Participants are monitored for adherence to physical activity and long-term effects of the intervention
Treatment Details
Interventions
- CME
- HIIT
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
University of Washington
Collaborator
Case Western Reserve University
Collaborator